Skip to main content

dtx

By Adam Ang | 01:44 am | December 16, 2021
The research targets people with complex regional pain syndrome, post-stroke pain, and other pain-induced conditions.
By Adam Ang | 02:19 am | November 11, 2021
It will focus on creating digital solutions for ophthalmic, neurological and psychiatric disorders.
By Adam Ang | 02:34 am | October 21, 2021
They will develop and commercialise three novel digital therapeutic products. 
By Adam Ang | 03:53 am | September 17, 2021
The app provides personalised treatment guidance to users based on their BP record, habit logs and behavioural changes.
By Laura Lovett | 03:50 pm | July 22, 2021
The new tool must be prescribed by a doctor, but is not intended to replace medications. 
By Mallory Hackett | 01:01 pm | April 07, 2021
The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company.   
By Dave Muoio | 04:04 pm | April 01, 2021
Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company's heyday.
By Dave Muoio | 02:12 pm | March 01, 2021
The investment from "a leading national Integrated Delivery Network" brings the Series D's total to $100 million.
By Dave Muoio | 03:06 pm | February 25, 2021
Industry regulatory leaders outline the best approaches for digital health companies looking to make sense of FDA's long-in-the-tooth enforcement discretion guidelines.
By Dave Muoio | 10:00 am | February 24, 2021
The randomized controlled trial of the jointly-developed digital therapeutics will be conducted using Verily's Project Baseline and enroll up to 540 patients.